Serum fgl2 levels elevated in patients with acute coronary syndrome (ACS)

HealthMED

Volumn 6, Issue 6, 2012, Pages 2062-2065

  Zheng, Zhenzhong ^a   Zhan, Junfeng ^a   Zhang, Yanglong ^a   Wei, Yunfeng ^a   Wang, Menghong ^a   Zheng, Zeqi ^a   Peng, Jintian ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

ACS; Fgl2

Indexed keywords

FIBRINOGEN; FIBRINOGEN LIKE PROTEIN 2; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENSINI SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

EID: 84865506948     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Schwartz BS, Levy GA, Fair DS, Edgington TS. Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med. 1982;155:1464-1479.
2. Zhu CL, Yan WM, Zhu F, Zhu YF, Xi D, Tian DY, Levy G, Luo XP, Ning Q. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J Gastroenterol. 2005;11:6936-6940.
3. Ghanekar A, Mendicino M, Liu H, He W, Liu M, Zhong R, Phillips MJ, Levy GA, Grant DR. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol. 2004; 172: 5693-5701.
4. Mendicino M, Liu M, Ghanekar A, He W, Koscik C, Shalev I, Javadi M, Turnbull J, Chen W, Fung L, et al. Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac engrafts. Circulation. 2005; 112: 248-256.
5. Doo YC, Park WJ, Park SH, et al. The optimal timing to measure C-reactive protein to predict cardiac events in patients with unstable angina. Korean CircJ. 2001; 31:290-296.
6. Gensini GG. A more meaningful scoring system fordetermining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606.
7. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction [published erratum appears in J Am Coll Cardiol 2001;37(3): 973]. J Am Coll Cardiol 2000; 36(3):959-69.
8. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108(14): 1664-1672.
9. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH; National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007; 115(13): e352-e355.